Advisors Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
7,555
-4,167
-36% -$818K 0.02% 682
2026
Q1
$2.3M Sell
11,722
-374
-3% -$72.7K 0.04% 555
2025
Q4
$2.1M Sell
12,096
-5,446
-31% -$992K 0.04% 583
2025
Q3
$3.34M Sell
17,542
-3,678
-17% -$653K 0.06% 438
2025
Q2
$3.81M Sell
21,220
-8,079
-28% -$1.4M 0.07% 389
2025
Q1
$4.96M Sell
29,299
-7,953
-21% -$1.31M 0.09% 281
2024
Q4
$5.62M Sell
37,252
-6,718
-15% -$1.04M 0.1% 249
2024
Q3
$6.83M Sell
43,970
-1,456
-3% -$217K 0.13% 197
2024
Q2
$6.22M Sell
45,426
-2,452
-5% -$336K 0.12% 206
2024
Q1
$6.37M Buy
47,878
+4,641
+11% +$602K 0.12% 212
2023
Q4
$5.96M Sell
43,237
-3,277
-7% -$431K 0.12% 204
2023
Q3
$5.67M Sell
46,514
-190
-0.4% -$25.3K 0.12% 199
2023
Q2
$6.56M Sell
46,704
-3,057
-6% -$421K 0.13% 170
2023
Q1
$7.04M Sell
49,761
-1,728
-3% -$247K 0.14% 165
2022
Q4
$8.05M Sell
51,489
-9,817
-16% -$1.41M 0.17% 134
2022
Q3
$7.52M Sell
61,306
-805
-1% -$106K 0.16% 142
2022
Q2
$8.26M Sell
62,111
-4,310
-6% -$587K 0.16% 134
2022
Q1
$9.09M Sell
66,421
-719
-1% -$100K 0.14% 154
2021
Q4
$11.6M Buy
67,140
+4,932
+8% +$750K 0.17% 122
2021
Q3
$9.04M Buy
62,208
+3,648
+6% +$534K 0.14% 145
2021
Q2
$7.73M Buy
58,560
+2,896
+5% +$379K 0.11% 176
2021
Q1
$7.14M Buy
55,664
+5,782
+12% +$712K 0.11% 182
2020
Q4
$5.94M Buy
49,882
+3,141
+7% +$383K 0.1% 198
2020
Q3
$5.35M Buy
46,741
+3,299
+8% +$390K 0.1% 186
2020
Q2
$4.95M Buy
43,442
+3,201
+8% +$340K 0.1% 204
2020
Q1
$3.23M Buy
40,241
+6,235
+18% +$646K 0.08% 261
2019
Q4
$3.63M Buy
34,006
+5,508
+19% +$574K 0.06% 336
2019
Q3
$3.05M Buy
28,498
+524
+2% +$53.8K 0.06% 387
2019
Q2
$2.85M Sell
27,974
-1,006
-3% -$96.7K 0.05% 421
2019
Q1
$2.61M Sell
28,980
-2,005
-6% -$174K 0.05% 449
2018
Q4
$2.58M Sell
30,985
-2,480
-7% -$233K 0.05% 423
2018
Q3
$3.61M Sell
33,465
-187
-0.6% -$20.5K 0.06% 374
2018
Q2
$3.7M Sell
33,652
-4,603
-12% -$480K 0.06% 385
2018
Q1
$3.94M Sell
38,255
-974
-2% -$99.8K 0.07% 392
2017
Q4
$3.86M Sell
39,229
-987
-2% -$93.6K 0.06% 402
2017
Q3
$3.77M Buy
40,216
+2,096
+5% +$223K 0.06% 422
2017
Q2
$4.24M Sell
38,120
-83
-0.2% -$8.78K 0.07% 379
2017
Q1
$3.75M Buy
38,203
+8,259
+28% +$787K 0.06% 423
2016
Q4
$2.75M Buy
29,944
+5,885
+24% +$507K 0.05% 536
2016
Q3
$2.04M Buy
24,059
+11,753
+96% +$987K 0.03% 617
2016
Q2
$1M Buy
12,306
+2,735
+29% +$208K 0.02% 877
2016
Q1
$684K Buy
9,571
+3,601
+60% +$241K 0.01% 982
2015
Q4
$425K Buy
5,970
+1,902
+47% +$128K 0.01% 1192
2015
Q3
$250K Sell
4,068
-2,668
-40% -$186K ﹤0.01% 1308
2015
Q2
$488K Sell
6,736
-2,195
-25% -$162K 0.01% 1131
2015
Q1
$686K Sell
8,931
-365
-4% -$26.1K 0.01% 986
2014
Q4
$623K Buy
9,296
+205
+2% +$12.9K 0.01% 999
2014
Q3
$552K Sell
9,091
-2,609
-22% -$161K 0.01% 998
2014
Q2
$687K Buy
11,700
+4,329
+59% +$254K 0.01% 934
2014
Q1
$427K Buy
7,371
+1,590
+28% +$85.2K 0.01% 1052
2013
Q4
$310K Sell
5,781
-657
-10% -$39K 0.01% 1090
2013
Q3
$398K Sell
6,438
-1,147
-15% -$68.7K 0.01% 968
2013
Q2
$460K Buy
+7,585
New +$452K 0.01% 880

Other funds holding DGX

Advisors Asset Management's DGX Position: Q2 2026 in Review

Advisors Asset Management reduced its Quest Diagnostics (DGX) stake by 36% in Q2 2026, selling an estimated $818K and leaving 7,555 shares worth $1.6M. The position accounts for 0.02% of the portfolio, ranked #682.

Advisors Asset Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.6M in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Advisors Asset Management held 7,555 shares of Quest Diagnostics worth $1.6M as of Q2 2026.
  • Advisors Asset Management sold 4,167 Quest Diagnostics shares in Q2 2026, an estimated $818K.
  • Quest Diagnostics made up 0.02% of Advisors Asset Management's portfolio in Q2 2026, its #682 holding.
  • Advisors Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Advisors Asset Management's Quest Diagnostics position peaked at $11.6M in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.